Moreover, a recent study has shown that in vivo, lysophosphatidic acid increased the progression of atherosclerosis and recruited leukocytes to the vessel wall during early atherogenesis via lysophosphatidic acid receptor-mediated release of endothelial CXCL1 (Zhou et al., 2011). The gene discussed is CXCL1; the disease is atherosclerosis.